Madeline Lillie, MD
Allergy · Amherst, NYNPI 1962482711
Payments from drug & device makers
Across 773 payments — averaging $26.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- AstraZeneca$3K
- Regeneron Healthcare Solutions, Inc.$3K
- GSK$3K
- CSL Behring$939
- Amgen$828
- plus $6K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 86 | $4,032 |
| AstraZeneca | 121 | $3,208 |
| Regeneron Healthcare Solutions, Inc. | 103 | $3,098 |
| GSK | 130 | $2,537 |
| CSL Behring | 33 | $939 |
| Amgen(2 entities) | 37 | $828 |
| Pfizer | 37 | $797 |
| Genentech USA, Inc. | 26 | $730 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $576 |
| Kaleo, Inc. | 28 | $484 |
| Optinose US, Inc. | 18 | $462 |
| Alk-abello, Inc | 16 | $383 |
| Biocryst US Sales Co., LLC | 19 | $367 |
| Teva Pharmaceuticals USA, Inc. | 13 | $307 |
| Incyte Corporation | 6 | $223 |
| Novartis | 5 | $212 |
| Pharming Healthcare, Inc. | 7 | $212 |
| Grifols USA, LLC | 6 | $200 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $197 |
| Boehringer Ingelheim | 13 | $175 |
| Octapharma USA, Inc. | 5 | $111 |
| Blueprint Medicines Corporation | 5 | $109 |
| USWM, LLC | 4 | $86 |
| Shire North American Group Inc | 4 | $62 |
| Biocryst Pharmaceuticals, Inc. | 2 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Sanofi-aventis U.S. LLC | 1 | $44 |
| Phadia US Inc. | 2 | $41 |
| Galderma Laboratories, L.p. | 2 | $33 |
| Covis Pharma GmbH | 2 | $30 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $22 |
| Cycle Pharmaceuticals Inc | 1 | $20 |
| Circassia Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
How this compares
$20,692 in reported general payments places this provider in the 80th percentile of 92 allergy providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Amherst
- Kathleen DonovanAmherst$16K
- Christopher SmithHorseheads$18M
- Marc BraunsteinHewlett$924K
- Allison RamseyRochester$904K
- Dariusz ChrostowskiWatertown$751K
- Anne MaitlandTarrytown$626K
- Yudhistira PersaudBronx$280K
- Alan KaufmanMount Vernon$227K
- Michael KatlanAlbany$91K
- Michel AklJamestown$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.